Search Results - "Ballesta, A.M"

Diagnostic and predictive value of urine PCA3 gene expression for the clinical management of patients with altered prostate-specific antigen by Rodón, N, Trías, I, Verdú, M, Román, R, Domínguez, A, Calvo, M, Banus, J.M, Ballesta, A.M, Maestro, M.L, Puig, X

“…Abstract Objective Analyze the impact of the introduction of the study of PCA3 gene in post-prostatic massage urine in the clinical management of patients with…”
Get full text

Usefulness of biochemical markers of bone turnover in assessing response to the treatment of paget’s disease by Alvarez, L, Guañabens, N, Peris, P, Vidal, S, Ros, I, Monegal, A, Bedini, J.L, Deulofeu, R, Pons, F, Muñoz-gomez, J, Ballesta, A.M

“…The aim of this study was to investigate the usefulness of biochemical markers of bone turnover for monitoring treatment efficacy of Paget’s disease of bone,…”
Get full text

Components of biological variation of biochemical markers of bone turnover in Paget’s bone disease by Alvarez, L., RicÓs, C., Peris, P., GuaÑabens, N., Monegal, A., Pons, F., Ballesta, A.M.

“…The aims of this study were to evaluate the components of biological variation of the new markers of bone turnover in patients with Paget’s bone disease and to…”
Get full text

Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy by Peris, P, Alvarez, L, Monegal, A, GuaÑabens, N, DurÁn, M, Pons, F, Martínez de Osaba, M.J, Echevarría, M, Ballesta, A.M, Muñoz-Gómez, J

“…The objective of this study was to evaluate the effect of surgical menopause and hormone replacement therapy (HRT) on the new biochemical markers of bone…”
Get full text

CA 125 in biological fluids by Molina, R, Filella, X, Jo, J, Agusti, C, Ballesta, A M

“…CA 125 is not a specific tumor marker, and is synthesized by normal and malignant cells of different origin (mainly in tissues derived from the müllerian…”
Get more information

S-100β and MIA in Advanced Melanoma in Relation to Prognostic Factors by J.M. AUGE, R. MOLINA, X. FILELLA, E. BOSCH, M. GONZALEZ CAO, S. PUIG, J. MALVEHY, T. CASTEL, A.M. BALLESTA

“…We compared the sensitivity and specificity of S-100 and MIA in advanced melanoma, in 96 patients with no evidence of disease (NED) and 86 patients with…”
Get full text

Clinical evaluation of free PSA/Total PSA (Prostate-specific Antigen) ratio in the diagnosis of prostate cancer by Filella, X, Alcover, J, Molina, R, Rodríguez, A, Carretero, P, Ballesta, A.M

“…The objective of this study was to evaluate the utility of the free/total prostate-specific antigen (PSA) ratio (per cent free PSA) in the diagnosis of…”
Get full text

The role of metalloproteinases in CCl4 induced fibrosis. Influence of zinc administration by Giménez, A., Gassó, M., Román, J., Caballeria, J., Deulofeu, R., Rubio, M., Parés, A., Ballesta, A.M., Rodés, J.

Get full text

Tumor markers (CEA, CA 125, CYFRA 21.1, SCC and NSE) in non small cell lung cancer (NSCLC) patients as an aid in histological diagnosis and prognosis: Comparison with the main clinical and pathological prognostic factors by Vinolas, N, Molina, R, Fuentes, R, Bover, I, Rifa, J, Moreno, V, Canals, E, Marquez, A, Barreiro, E, Borras, J, Filella, X, Jo, J, Navarro, X, Viladiu, P, Ballesta, A.M

Get full text

Influence of AFP, CEA and PSA on the in vitro production of cytokines by Filella, X, Molina, R, Alcover, J, Coca, F, Zarco, M A, Ballesta, A M

“…Several studies have demonstrated a decreased cytokine production in patients with cancer. Likewise, there is some evidence showing that tumor markers may play…”
Get more information

Does urinary deoxipyridinoline improve the diagnostic accuracy of urinary pyridinoline as a bone resorption marker in Paget's disease? by Alvarez, L., Guañabens, N., Peris, P., Monegal, A., Bedini, J.L., Aibar, C., Muñoz-Gómez, J., Gómez, J., Ballesta, A.M.

Get full text

CYFRA 21-1 in lung cancer: comparison with CEA, CA 125, SCC and NSE serum levels by Molina, R, Agusti, C, Mañe, J M, Filella, X, Jo, J, Joseph, J, Giménez, N, Estapé, J, Ballesta, A M

“…CYFRA 21-1, CEA, CA 125, SCC and NSE serum levels were determined in 50 healthy subjects and in 189 patients with primary lung cancer (101 with locoregional…”
Get more information

S-adenosyl l-methionine effect on hepatic allografts procured from non–heart-beating donor pigs by Net, M, Garcia-Valdecasas, J.C, Deulofeu, R, Gonzalez, X, Palacin, J, Almenara, R, Valero, R, Lopez-Boado, M, Angás, J, Elena, M, Ballesta, A.M, Visa, J

Get full text

Impaired ex vivo production of TNF-alpha by whole blood cells in the presence of PSA by Filella, X, Molina, R, Ballesta, A M

Get more information

Use of CA 19-9 in the early detection of recurrences in colorectal cancer: comparison with CEA by Filella, X, Molina, R, Piqué, J M, Garcia-Valdecasas, J C, Grau, J J, Novell, F, Astudillo, E, de Lacy, A, Daniels, M, Ballesta, A M

“…The serum levels of CA 19-9 were determined in the follow-up of 370 patients with colorectal cancer and compared with CEA. An increase in CA 19-9 preceded…”
Get more information

Serum phosphohexose isomerase activities in patients with colorectal cancer by Filella, X, Molina, R, Jo, J, Mas, E, Ballesta, A M

“…Pretreatment levels of phosphohexose isomerase (PHI) were above the cutoff limit of 107 IU/l in 41% of patients with benign intestinal diseases and in 46% of…”
Get more information

Evaluation of the ion selective electrodes module in the DAX analyzers by Bedini, J.L., Mas, E., Deulofeu, R., Marín, J.L., Ballesta, A.M.

“…The analytical performance of the ion selective electrodes module of the DAX analyzers was studied according to guidelines for ISE evaluation recommended by…”
Get full text

Tumor markers in patients with chronic renal failure by Filella, X, Cases, A, Molina, R, Jo, J, Bedini, J L, Revert, L, Ballesta, A M

“…In order to evaluate the specificity of tumor markers in chronic renal failure, we have determined serum levels of carcinoembryonic antigen (CEA), carbohydrate…”
Get more information

Multicentre clinical evaluation of the COBAS CORE CEA, CA 125 II and PSA tumor marker assays by Filella, X, Ballesta, A M, Fox, M, Mitchell, H, Molina, R, Pürstner, P, Thome, H

“…The aim of our study was to evaluate the clinical usefulness of the tumor markers CEA, CA 125 and PSA using the COBAS CORE system from Roche Diagnostic…”
Get more information

Relationship of CA 125 and CA 19.9 with lung carcinoma histological subtype: preliminary study by Molina, R, Santabarbara, P, Filella, X, Mengual, P, Ballesta, A M, Balague, A

“…The aim of this work was to study the possible utility of simultaneous determination of CA 125 and CA 19.9 in patients with lung cancer. Serum levels of both…”
Get more information